20-176 - Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Status: openA Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
Multiple Sclerosis
Description
This is a randomized trial for multiple sclerosis. The purpose is to evaluate disability risk between early aggressive therapy and traditional first-line therapy. Subject will be randomized to receive one of the two treatment types and will be evaluated over a 4 year period.
Sponsors
This trial is sponsored by Patient-Centered Outcomes Research Institute (PCORI).Interested in Clinical Trial?
https://www.clinicaltrials.gov/ct2/show/record/NCT03500328?term=NCT03500328&draw=2&rank=1
Contact the Clinical Trial Coordinator
If you have questions get in touch with this Clinical Trial’s Coordinator by phone at +1 (251) 665-8375 or by email at dlwilliams@health.southalabama.edu.
